Dr. Steven B. Harris
Steven
B. Harris, M.D. is Director of Research
at Critical Care Research.
Steve earned his B.S. degree in chemistry (A.C.S) and his M.D. from the
University of Utah. He’s licensed to practice medicine in Utah and
California, and has been board-certified in internal medicine and
geriatrics. He studied gerontology with Roy Walford, MD, at UCLA.
Steve is presently engaged almost full-time in experimental physiology
at USDA approved private biomedical animal research institution,
Critical Care Research (Rancho Cucamonga, California). This research involves
development of resuscitation physiology involving delivery of
lipid-soluble drugs to the resuscitated brain (dog model), and also
experimental hypothermia induction for resuscitation and cerebral
protection using post-resuscitation hypothermic perfluorocarbon lung
lavage (also dog model). Some of this research has been published in
Resuscitation 50:189-204, 2001.
His experience with formulation of microemulsions of lipid soluble drugs
for resuscitation has led him to pursue collaborative ventures involving
microemulsification technology for delivery of water insoluble drugs and
nutrients for animal feed, veterinary and medical applications. He is
pursuing patents for microemulsion formulations of CoQ10 and propofol.
A key propofol/Solutol HS-15 microemulsion patent has been granted to
Steven B. Harris
and Nick Huang in Australia (Pat. No. 2005215517), Canada (Pat. No.
2,556,185, etc), China, India, Japan (allowed, not yet issued), Mexico,
New Zealand, South Africa, Russia, and Ukraine. Major claims have been
allowed (not yet issued) in the U.S. It is pending in several other
domains (such as the E.U.). This inexpensive, clear, non-bacterial
growth-supporting microemulsion formulation of propofol should
eventually replace all existing preparations of this important surgical
general anesthetic agent. These patented domains cover half the world’s
population. Steve’s team is seeking venture capital. This
formulation of propofol
has been shown in horses to be equivalent to standard preparations: See
pubmed 6948589.
Read his
LinkedIn profile.